Fundraising Fox

Milenko Cicmil

Investor

Partner at Cure Ventures

Boston, Massachusetts

Writes $100K – $5M checks · typically $1.5M

About

Associated with portfolio company Tasca Therapeutics, which works on post-translational modification to expand the druggable proteome.

Experience

  1. University of ReadingVisiting Research Fellow at Univ. of Reading, UKcurrent2020 — presentUnited Kingdom
  2. Cure VenturesPartnercurrent2021 — presentUnited States
  3. AMP DiscoveryChairman Of The Board AMP Discovery2021 — 2022
  4. IpsenVice President Global Head of external Innovation2019 — 2021Cambridge, Massachusetts, USA
  5. FogPharmaVice President - Translational Biology2017 — 2019Cambridge, USA
  6. MerckDirector at Merck Innovation Hub2016 — 2017Cambridge USA
  7. MerckDirector Pharmacology Immuno-Oncology and Immunomodulation2013 — 2016Greater Boston Area
  8. MerckDirector In vivo Pharmacology R&I2011 — 2013Boston, US
  9. AstraZenecaGroup Leader Integrative Pharmacology Discovery Bioscience - Inflammation2007 — 2011Leicester, United Kingdom
  10. AstraZenecaSenior Research Scientist2004 — 2007Leicester, United Kingdom
  11. GE HealthcareSenior Research Scientist2002 — 2004Amersham UK
  12. Cancer Research UKTranslational Science - Research Fellow2000 — 2002London, United Kingdom

Skills & more

Biochemistry5Biomarker Discovery7Biomarkers7Biotechnology5CRO3Cell Culture3Clinical Development6DMPK2Drug Design4Drug Development14Drug Discovery25In Vitro7
+6 moreIn VivoLead ChangeLifesciencesPharmaceutical IndustryPharmacologyTarget Identification

From Milenko's professional profile.

Colleagues at Cure Ventures

Frequently asked questions

Who is Milenko Cicmil?
Associated with portfolio company Tasca Therapeutics, which works on post-translational modification to expand the druggable proteome.
Where does Milenko Cicmil work?
Milenko Cicmil is Partner at Cure Ventures.
What check size does Milenko Cicmil write?
Milenko Cicmil typically writes checks of $100K – $5M.
Where did Milenko Cicmil go to school?
Milenko Cicmil studied at King's College London (Bachelor’s Degree, Cell/Cellular and Molecular Biology); University of Reading (Doctor of Philosophy (Ph.D.), Molecular Pharmacology).

Same school

Shared employers